[go: up one dir, main page]

FI920734L - Ketosyror innehaollande kinoliner med leukotrienantagonisteffekt - Google Patents

Ketosyror innehaollande kinoliner med leukotrienantagonisteffekt Download PDF

Info

Publication number
FI920734L
FI920734L FI920734A FI920734A FI920734L FI 920734 L FI920734 L FI 920734L FI 920734 A FI920734 A FI 920734A FI 920734 A FI920734 A FI 920734A FI 920734 L FI920734 L FI 920734L
Authority
FI
Finland
Prior art keywords
leucotriena
kinoliner
ketosyror
antagonisteffect
innehaollande
Prior art date
Application number
FI920734A
Other languages
English (en)
Other versions
FI920734A7 (fi
FI920734A0 (fi
Inventor
Michel L Belley
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of FI920734A0 publication Critical patent/FI920734A0/fi
Publication of FI920734A7 publication Critical patent/FI920734A7/fi
Publication of FI920734L publication Critical patent/FI920734L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI920734A 1991-02-21 1992-02-20 Ketosyror innehaollande kinoliner med leukotrienantagonisteffekt FI920734L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65893191A 1991-02-21 1991-02-21

Publications (3)

Publication Number Publication Date
FI920734A0 FI920734A0 (fi) 1992-02-20
FI920734A7 FI920734A7 (fi) 1992-08-22
FI920734L true FI920734L (fi) 1992-08-22

Family

ID=24643302

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920734A FI920734L (fi) 1991-02-21 1992-02-20 Ketosyror innehaollande kinoliner med leukotrienantagonisteffekt

Country Status (17)

Country Link
EP (1) EP0500360B1 (fi)
JP (1) JPH0788361B2 (fi)
KR (1) KR920016423A (fi)
CN (1) CN1065062A (fi)
AT (1) ATE154801T1 (fi)
AU (1) AU648385B2 (fi)
CA (1) CA2061675C (fi)
CS (1) CS47192A3 (fi)
DE (1) DE69220517T2 (fi)
ES (1) ES2104821T3 (fi)
FI (1) FI920734L (fi)
HU (1) HU9200552D0 (fi)
IE (1) IE920499A1 (fi)
IL (1) IL100985A0 (fi)
MX (1) MX9200714A (fi)
NO (1) NO920681L (fi)
ZA (1) ZA921232B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
GB9216768D0 (en) * 1992-08-07 1992-09-23 Leo Pharm Prod Ltd Chemical compounds
KR19990008148A (ko) * 1995-04-28 1999-01-25 다께다 구니오 관절염 치료 조성물
AU3868497A (en) * 1996-08-26 1998-03-19 Yamanouchi Pharmaceutical Co., Ltd. Benzenesulfone compounds and salts thereof
ATE203668T1 (de) * 1998-07-14 2001-08-15 Alcon Lab Inc Verwendung von 11-(3-dimethylaminopropyliden)-6, 11-dihydrodibenz(b,e)oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation
ES2327762T3 (es) * 2004-04-21 2009-11-03 Teva Pharmaceutical Industries Ltd Procedimiento para preparar montelukast sodico.
ITMI20050247A1 (it) 2005-02-18 2006-08-19 Chemi Spa Processo per la preparazione di montelukast
WO2006131782A1 (en) * 2005-06-07 2006-12-14 Glade Organics Private Limited Process for the manufacture of methyl-2-(3-(2-(7-chloro-2-quinolinyl-ethenyl)-phenyl)-3-oxopropyl) benzoate
EP1904448B1 (en) 2005-07-05 2011-02-02 Teva Pharmaceutical Industries, Ltd. Purification of montelukast
CN101356158B (zh) * 2005-11-18 2011-12-14 斯索恩有限公司 用于制备孟鲁司特的中间体及相关的化合物
AR056815A1 (es) * 2005-11-18 2007-10-24 Synthon Bv PROCESO PARA PREPARAR MONTELUKAST, INTERMEDIARIOS DEL MISMO Y SUS SALES DE ADICIoN Y PROCEDIMIENTO DE PURIFICACIoN DE ÉSTOS Y DE MONTELUKAST
KR20090080038A (ko) * 2006-09-15 2009-07-23 씨아이피엘에이 엘티디. 몬테루카스트의 제조방법 및 그의 중간체
ES2320077B1 (es) * 2007-07-31 2010-02-26 Moehs Iberica, S.L. Proceso de preparacion de un antagonista de leucotrienos y de un intermedio del mismo.
CN101851196B (zh) * 2010-05-28 2011-07-27 中国科学院昆明植物研究所 2-(1h)喹啉酮衍生物,其药物组合物及其制备方法和用途
AU2012320010B2 (en) * 2011-07-26 2017-03-30 Sun Pharma Advanced Research Company Ltd. Quinoline-, quinoxaline or benzothiazole based cysteinyl leukotriene antagonists (LTD4)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59889B1 (en) * 1986-02-14 1994-04-20 Merck Frosst Canada Inc 2-substituted quinoline dioic acids
EP0318093A3 (en) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylquinoline diacids and their use as medicaments
EP0349062A1 (en) * 1988-06-27 1990-01-03 Merck Frosst Canada Inc. Quinoline ether alkanoic acid
NZ233752A (en) * 1989-05-24 1993-05-26 Merck Frosst Canada Inc Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EP0500360A1 (en) 1992-08-26
FI920734A7 (fi) 1992-08-22
NO920681D0 (no) 1992-02-20
IE920499A1 (en) 1992-08-26
FI920734A0 (fi) 1992-02-20
EP0500360B1 (en) 1997-06-25
CA2061675C (en) 2002-12-17
AU648385B2 (en) 1994-04-21
JPH0525135A (ja) 1993-02-02
ES2104821T3 (es) 1997-10-16
JPH0788361B2 (ja) 1995-09-27
KR920016423A (ko) 1992-09-24
ZA921232B (en) 1992-10-28
DE69220517T2 (de) 1997-12-18
IL100985A0 (en) 1992-11-15
DE69220517D1 (de) 1997-07-31
HU9200552D0 (en) 1992-05-28
AU1111992A (en) 1992-08-27
CA2061675A1 (en) 1992-08-22
NO920681L (no) 1992-08-24
CS47192A3 (en) 1992-10-14
MX9200714A (es) 1992-10-01
ATE154801T1 (de) 1997-07-15
CN1065062A (zh) 1992-10-07

Similar Documents

Publication Publication Date Title
FI924814A7 (fi) Medicinska aotergivningsanordning foer roentgenbild med automatisk exponeringsfunktion
FI924822A0 (fi) Tillslutningsanordning med en separerbar taetning
FI923888L (fi) Tillslutare med automatisk tryckutjaemning
FI922193L (fi) Expansionspropp med friktionsminskande beskiktning
FI922162A7 (fi) Doerrstaengningsanordning med laosningsmekanism foer hissar
FI921840L (fi) Monoalkylfosfinat- och monoalkylfosfonatsampolymerer med laog molekylvikt
FI922226L (fi) Elektrostatisk hoegspaenningsmaolfaergssprutpistol med laogt tryck
FI920718L (fi) Vaetskefoerdelare med indraget foerdelningsmunstycke
FI914594L (fi) Kiseldioxidpoleruppslamningar med laog natrium- och metallhalt
FI923987A7 (fi) Radiomottagare och- saendare med skillnadsfunktion
FI924462L (fi) Foerpackningssystem omfattande paose med perforeringsroer
FI925516L (fi) Arbetshuvud med roterbart monterad kedjesaog
FI921410L (fi) Lyftanordningsmaterial med rivraemsor
FI923054L (fi) Vinylmonomerkomposition med accelererad ythaerdning
FI920971L (fi) Slangformigt livsmedelshoelje med foerbaettrad avskalning
FI922144A7 (fi) Baeranordning med upprivbara bandsegment
FI925148L (fi) Haordmetallkropp med oekad slitstyrka
FI920440L (fi) Squid-maetningsanordning foersedd med skyddsorgan
FI923497A7 (fi) Roterande anslutning med laonglivad taetning
FI925649L (fi) Karboxivinylpolymerer med newtonsk viskositet
FI923541L (fi) Schaberanordning med schaberbalk
FI922774L (fi) Effektfaktorkorrigerande enstegsomvandlare med en isolerad utgaong
FI924692A0 (fi) Omkopplingsventil med lufttillfoerselanordning
FI920734L (fi) Ketosyror innehaollande kinoliner med leukotrienantagonisteffekt
FI930110A0 (fi) Dieseloljor med laog svavelhalt innehaollande organometalliska komplex

Legal Events

Date Code Title Description
FD Application lapsed